FAN
UTHR icon

Financial Advisors Network’s United Therapeutics UTHR Stock Holding History

Financial Advisors Network’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-51
Closed -$8.14K – 438
2016
Q4 		$8.14K Buy
+51
New +$6.51K 0.01% 272

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Financial Advisors Network's UTHR Position: Q1 2017 in Review

Financial Advisors Network sold out of United Therapeutics (UTHR) in Q1 2017, closing a stake of 51 shares — an estimated $8.14K sold.

Financial Advisors Network first reported a position in UTHR in Q4 2016 and held it in 1 quarter. The position peaked at $8.14K in Q4 2016. 411 funds tracked by Wall St. Rank hold UTHR as of Q1 2017.

  • Financial Advisors Network reported no remaining United Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Financial Advisors Network sold 51 United Therapeutics shares in Q1 2017, an estimated $8.14K.
  • Financial Advisors Network first reported a position in United Therapeutics in Q4 2016 and held it in 1 quarter.
  • Financial Advisors Network's United Therapeutics position peaked at $8.14K in Q4 2016.
  • 411 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2017.

Based on Financial Advisors Network's 13F filing for Q1 2017, filed 17 May 2017.